New FDA Guidance Gives the Tobacco Industry a Free Pass to Put Illegal Products on the Market
Public-health advocates say the guidance gives tobacco makers a de facto pass to sell products without the usual FDA authorization.
- The U.S. Food and Drug Administration issued new guidance allowing tobacco products to remain on the market while pending review. This policy effectively grants companies a "free pass" for unauthorized products.
- Facing pressure from the White House, the agency authorized more flavored cigarettes despite public health concerns. Currently, 8 percent of youth use flavored e-cigarettes, raising alarm among health advocates.
- Under the new FDA policy, simply submitting an application provides companies a "safe harbor" from enforcement. Products may be sold without full review or proven safety standards.
- Criticism from the Campaign for Tobacco-Free Kids suggests the move undermines the Federal Tobacco Control Act. Officials claim the policy fails to protect children from illegal products.
- Broader concerns persist as the FDA attempts to balance industry demands with its mandate to regulate tobacco sales. Observers warn this shift sets a dangerous precedent for future enforcement.
38 Articles
38 Articles
What did the FDA vaping guidance change?
FDA policy shift enabling flavored vapes The provided coverage says the FDA issued new guidance that could pave the way for major tobacco companies to begin selling flavored vapes , and that the move came less than a week after executives met with President Trump . A separate related story…
British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read
British American Tobacco shares jumped 5.82% in London to £46.34 after the FDA signaled a softer enforcement stance on some e-cigarette and nicotine pouch products. A U.S. judge also dismissed BAT’s North Korea sanctions case following a $630 million settlement. The FTSE 100 slipped 0.04%. BAT’s U.S.-listed ADR closed up 5.3% at $63.64. The post British American Tobacco Stock Jumps as FDA Shift Gives Vuse and Velo a Cleaner Read appeared first o…
Coverage Details
Bias Distribution
- 59% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium
